Surgery Partners (SGRY) Shares Outstanding (2013 - 2026)

Surgery Partners' Shares Outstanding history runs 14 years deep, the most recent figure standing at $130.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 2.03% year-over-year to $130.8 million; the TTM figure through Mar 2026 stood at $130.8 million (up 2.03% YoY), while the FY2025 annual figure was $129.3 million, up 1.74% from the prior year.
• Shares Outstanding came in at $130.8 million for Q1 2026 at Surgery Partners, up from $129.3 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $130.8 million in Q1 2026 to a low of $89.9 million in Q1 2022.
• A 5-year average of $120.9 million and a median of $127.1 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding surged 50.09% in 2022 and grew 0.41% in 2024, its largest moves.
• Surgery Partners' Shares Outstanding stood at $126.0 million in 2022, then advanced by 0.5% to $126.6 million in 2023, then grew by 0.41% to $127.1 million in 2024, then advanced by 1.74% to $129.3 million in 2025, then advanced by 1.14% to $130.8 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $130.8 million, $129.3 million, and $129.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison